Lung Cancer | Tumor

CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.

Newly-Approved Lorbrena Shows Better Responses in Patients With Brain Metastases

March 31st 2021

The FDA recently approved an expanded indication for Lorbrena as a first-line treatment option for a subset of lung cancer that has spread to the brain. Compared to previously-approved options, experts say Lorbrena is more effective.

Opdivo With or Without Yervoy Did Not Prolong Survival in Small Cell Lung Cancer

March 29th 2021

Previously, treatments for patients with extensive-disease small cell lung cancer were limited with a poor prognosis. Researchers sought to investigate if Opdivo plus Yervoy or Opdivo alone would improve survival.

CURE’s Clinical Trial Corner: March 2021

March 25th 2021

Here is a list of some recent trials that launched within the cancer space in March.

FDA Fast Track of Novel Drug May Open Doors for Certain Patients with Non-Small Cell Lung Cancer

March 15th 2021

The FDA’s fast track designation to poziotinib for use in previously treated patients with non-small cell lung cancer whose disease harbors a certain genetic mutation, may open the doors to an accelerated approval.

The Future of Adoptive Cellular Therapy in Lung Cancer

March 15th 2021

In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.

Trial Assessing Novel Drug in Patients With Previously Treated Non-Small Cell Lung Cancer Fails to Meet its Goal of Improving Survival

March 13th 2021

A trial investigating a novel drug plus the chemotherapy docetaxel failed to show a survival benefit in patients with previously treated locally advanced or metastatic non–small cell lung cancer.

Geriatric Assessment and More Inclusive Clinical Trials Needed for Older Adults with Lung Cancer

March 12th 2021

As the population ages, the incidence of older adults being diagnosed with lung cancer is increasing, though data on how to specifically treat this population are lacking.

The NCCN Releases Updated Protocol for Management of COVID-19 in Patients with Cancer

March 12th 2021

The National Comprehensive Cancer Network (NCCN) recently released the best practices for the management of COVID-19 infection in patients with cancer.

'A Breath of Fresh Air': FDA's Cosela Approval May Improve Quality of Life in Lung Cancer

March 12th 2021

The FDA’s recent approval of Cosela to reduce the frequency of chemotherapy-induced bone marrow suppression in adults who are receiving certain types of chemotherapy for extensive-stage small cell lung cancer is a “breath of fresh air,” according to an expert.

Looking at the Big Picture of Small Cell Lung Cancer

March 10th 2021

An expert discusses ways that small cell lung cancer is diagnosed, how to treat it and how to pivot if the disease spreads or recurs. He also focuses on efforts in the clinical trial space to potentially treat patients more effectively.

Task Force Recommends Lowering Age for Lung Cancer Screening, Including Individuals with Shorter Smoking History

March 10th 2021

The US Preventive Services Task Force now recommends lowering the age and smoking history requirements for people to receive annual lung cancer screening.

GO2 Foundation Leads Study to Improve Participation of Black Communities in Lung Cancer Clinical Trials

March 9th 2021

The GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the launch of an important multi-institutional study to determine how to improve the participation of Black communities in lung cancer clinical trials.

7 Recent News and Updates in Lung Cancer

March 8th 2021

A roundup of some of the latest news and updates for patients with lung cancer from CURE®.

Educated Patient® Lung Cancer Summit: March 6, 2021

March 6th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

FDA, Drug Manufacturer Pull Keytruda’s Indication for Small Cell Lung Cancer

March 5th 2021

Merck – the manufacturer of Keytruda (pembrolizumab) – is pulling the immunotherapy drug’s indication for patients with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy and one or more prior line of therapy.

Organization Urges That Patients With Lung Cancer Worldwide Have Access to COVID-19 Vaccine

March 5th 2021

The International Association for the Study of Lung Cancer recently joined more than 100 cancer centers and organizations in urging leading public health officials to prioritize administering the COVID-19 vaccine to cancer survivors and patients undergoing treatment for the disease.

FDA Approves Lorbrena as First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer

March 4th 2021

This approval expands a previous accelerated approval of the drug in 2018, allowing it for use in patients with brain metastases.

Front-Line Opdivo-Yervoy Combo Plus 2 Cycles of Chemo Shows Significant Survival Benefit in Patients with Advanced Non-Small Cell Lung Cancer

March 2nd 2021

The data, according to the study authors, confirm a recent Food and Drug Administration approval of the regimen and support its use in the front-line treatment of patients with advanced non-small cell lung cancer.

A Non-Small Cell Lung Cancer Survivor Shares Her Story

March 2nd 2021

A young mother and athlete discusses receiving a shocking diagnosis of stage 4 lung cancer and her incredible response to treatment with a single, targeted drug.

FDA Approves Front-Line Libtayo for Advanced Non-Small Cell Lung Cancer Subset

February 22nd 2021

The Food and Drug Administration has approved first-line Libtayo (cemiplimab-rwlc) monotherapy for patients with advanced non-small cell lung cancer with a PD-L1 expression of 50% or greater.

CURE®'s EDUCATED PATIENT® Webinar: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing

February 18th 2021

Watch CURE®'s EDUCATED PATIENT® Webinar: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing.

Bob Dole Announces Lung Cancer Diagnosis

February 18th 2021

Former longtime Kansas senator Bob Dole announced that he will be undergoing treatment for lung cancer next week.

Controversial Radio Host Rush Limbaugh Dies 1 Year After Advanced Lung Cancer Diagnosis

February 17th 2021

Conservative radio host Rush Limbaugh, 70, has died after receiving an advanced lung cancer diagnosis one year ago.

FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy in Certain Patients With Lung Cancer

February 12th 2021

The FDA approved Cosela, a first-in-its-class therapy to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage small cell lung cancer.

Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing

February 9th 2021

CURE will host a webinar, sponsored by Amgen, in which panelists from several cancer organizations will discuss ways to improve awareness around biomarker testing, improve coordination of care for patients with lung cancer and remove barriers to access to care.

FDA Approves Tepmetko for Adults With Non-Small Cell Lung Cancer Whose Disease Harbors A Certain Mutation

February 3rd 2021

The Food and Drug Administration has granted an accelerated approval to Tepmetko for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose disease harbors mesenchymal-epithelial transition (MET) exon 14 skipping alterations.

Sotorasib Shows Promise in Non-Small Cell Lung Cancer Subset

February 3rd 2021

Treatment with sotorasib induced a 6.8-month median progression-free survival in patients with KRAS G12C–mutated advanced non-small cell lung cancer.

At-Home Prehab May Improve Outcomes Following Lung Cancer Surgery

February 2nd 2021

Recent study results demonstrated that an at-home prehabilitation program may improve surgical outcomes in patients with lung cancer.

COVID-19 Pandemic May Negatively Impact Patients’ Ability to Access Care for Lung Cancer

February 2nd 2021

A survey conducted by the LUNGevity Foundation determined that 96% of patients with lung cancer felt that they were concerned about the COVID-19 pandemic affecting their treatment.

Patients with Lung Cancer Have Experienced More Psychological Distress During COVID-19 Than Those With Other Cancer Diagnoses

February 2nd 2021

New study results demonstrate that patients with lung cancer have experienced more worries and general distress during the COVID-19 pandemic compared to other patients with cancer.

NEXT PAGE
PREVIOUS PAGE